P.V. Suryakiran

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo et al. · The Lancet Infectious Diseases · 2016 · 187 citations

Vaccination, Vaccine Safety, Vaccinology +12

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

Kong Boo Phua, Filip Lim, YL Lau et al. · Vaccine · 2009 · 142 citations

Vaccination, Vaccine Safety, Maternal Immunization +8

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

A. Duncan Steele, Kathleen M. Neuzil, Nigel A. Cunliffe et al. · BMC Infectious Diseases · 2012 · 139 citations · Full text

Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age

Khalequ Zaman, David A. Sack, Mohammad Yunus et al. · Vaccine · 2009 · 109 citations

Vaccination, Vaccine Development, Oral Poliovirus Vaccines +8

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson et al. · Human Vaccines & Immunotherapeutics · 2014 · 99 citations · Full text

Hpv-16/18 As04-adjuvanted Vaccine, Immunodeficiencies, Immunology +17